DOJ Announces Controlled Substances Act Scheduling Changes for FDA-Approved Marijuana and State-Licensed Medical Marijuana Products
On April 23, 2026, the U.S. Department of Justice (DOJ), in conjunction with the Drug Enforcement Administration, announced that pursuant to President Trump’s December 18, 2025, Executive Order…
Read the full articleYou might also wanna read
US Justice Department reclassifies cannabis from Schedule I to Schedule III drug
Medical marijuana was moved into a lower category of drugs in order to increase research and access.
bbc.com·2mo agoHow do marijuana laws differ between states?
As of April 2026, recreational cannabis is legal in 24 states and Washington, DC, while medical marijuana has been legalized in an additiona
Future-enable controlled substance ordering to achieve compliance and speed
The DEA is launching its new Controlled Substance Ordering System (CSOS) on December 9, 2024, to facilitate electronic ordering of controlle
Adaptive Networks: Why Supply-Side Enforcement Cannot Stop Fentanyl
The Trump administration has made countering fentanyl a core tenet of its national security policy. In January 2025, President Trump signed
New York Cannabis Board Approves 24 Licenses and Expands Medical Marijuana Access for Out-of-State Patients
New York regulators have approved 24 new adult-use marijuana licenses while adopting updated rules for the state’s medical cannabis program,
themarijuanaherald.com·5d agoTrucking coalition seeks federal marijuana test plan
A two-page letter outlined precautions the government agencies should take as the DEA prepares to downgrade marijuana’s Schedule I classific
Comments
Sign in to join the conversation.
No comments yet. Be the first.